Praxis Precision Medicines Provides Corporate Update and Reports Fourth Quarter and Full-Year 2025 Financial Results Life Science Investing
Gain Therapeutics to Present at Oppenheimer 36th Annual Healthcare Life Sciences Conference Life Science Investing
Covalon Announces Conference Call to Discuss First Quarter Fiscal 2026 Results Life Science Investing
Leading Scientists Demonstrate How Seer's Proteograph Product Suite Advances Cardiovascular and Neurodegenerative Research at US HUPO 2026 Life Science Investing
Kymera Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026 Life Science Investing
Eupraxia Pharmaceuticals Announces Pricing of US$55 Million Public Offering of Common Shares and Pre-Funded Warrants Life Science Investing
argenx to Report Full Year 2025 Financial Results and Fourth Quarter Business Update on February 26, 2026 Biotech Investing
BriaCell and BriaPro Enter Into Asset Purchase Agreement for Exclusive Soluble CD80 License Biotech Investing
Charles River Laboratories Announces Fourth-Quarter and Full-Year 2025 Results and Provides 2026 Guidance Life Science Investing
Axsome Therapeutics to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference Life Science Investing
HCW Biologics Announces Pricing of $1.5 Million Follow-On Offering Priced At-The-Market Under NASDAQ Rules Life Science Investing
BriaCell Receives Positive Recommendation from Data Safety Monitoring Board for Phase 3 Study in Metastatic Breast Cancer
